Possible Association Between Melanoma Arising from Congenital Naevus and Oestrogen or Progesterone Receptor Expression: Clinicopathological Analysis
DOI:
https://doi.org/10.2340/actadv.v103.5206Keywords:
estrogen receptor, histological techniques, melanoma, Nevus, progesterone receptorAbstract
Abstract is missing (Short communication)
Downloads
References
Zagouri F, Dimitrakakis C, Marinopoulos P, Tsigginou A, Dimopoulos MA. Cancer in pregnancy: disentangling treatment modalities. ESMO Open 2016; 1: 1-6.
https://doi.org/10.1136/esmoopen-2015-000016 DOI: https://doi.org/10.1136/esmoopen-2015-000016
Still R, Brennecke S. Melanoma in pregnancy. Obstet Med 2017; 10: 107-112.
https://doi.org/10.1177/1753495X17695001 DOI: https://doi.org/10.1177/1753495X17695001
Enninga EA, Holtan SG, Creedon DJ, Dronca RS, Nevala WK, Ognjanovic S, et al. Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma. Mayo Clin Proc 2014; 89: 520-535.
https://doi.org/10.1016/j.mayocp.2014.01.006 DOI: https://doi.org/10.1016/j.mayocp.2014.01.006
Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-168.
Ellis DL, Wheeland RG. Increased nevus estrogen and progesterone ligand binding related to oral contraceptives or pregnancy. J Am Acad Dermatol 1986; 14: 25-31.
https://doi.org/10.1016/S0190-9622(86)70002-9 DOI: https://doi.org/10.1016/S0190-9622(86)70002-9
Caldarola G, Battista C, Pellicano R. Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. Clin Ther 2010; 32: 57-59.
https://doi.org/10.1016/j.clinthera.2010.01.011 DOI: https://doi.org/10.1016/j.clinthera.2010.01.011
Dika E, Fanti PA, Vaccari S, Capizzi E, Degiovanni A, Gobbi A, et al. Oestrogen and progesterone receptors in melanoma and nevi: an immunohistochemical study. Eur J Dermatol 2017; 27: 254-259.
https://doi.org/10.1684/ejd.2017.3019 DOI: https://doi.org/10.1684/ejd.2017.3019
Lyn MD, Robin LT, Frederick CK, Martin CM, Arthur JS. Estrogen and progesterone receptor analysis in pregnancy-associated melanoma: absence of immunohistochemically detectable hormone receptors. Hum Pathol 1994; 25: 36-41.
https://doi.org/10.1016/0046-8177(94)90168-6 DOI: https://doi.org/10.1016/0046-8177(94)90168-6
Dika E, Patrizi A, Lambertini M, Manuelpillai N, Fiorentino M, Altimari A, et al. Estrogen receptors and melanoma: a review. Cells 2019; 8: 1463.
https://doi.org/10.3390/cells8111463 DOI: https://doi.org/10.3390/cells8111463
Dika E, Lambertini M, Lauriola M, Veronesi G, Ricci C, Tartari F, et al. Female melanoma and estrogen receptors expression: an immunohistochemical pilot study. Melanoma Res 2022; 32: 231-240.
https://doi.org/10.1097/CMR.0000000000000826 DOI: https://doi.org/10.1097/CMR.0000000000000826
Natale CA, Li J, Zhang J, Dahal A, Dentchev T, Stanger BZ, et al. Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade. Elife 2018; 7: e31770.
https://doi.org/10.7554/eLife.31770 DOI: https://doi.org/10.7554/eLife.31770
Todd SP, Driscoll MS. Prognosis for women diagnosed with melanoma during, before, or after pregnancy: weighing the evidence. Int J Womens Dermatol 2017; 3: 26-29.
https://doi.org/10.1016/j.ijwd.2016.12.004 DOI: https://doi.org/10.1016/j.ijwd.2016.12.004
Additional Files
Published
How to Cite
License
Copyright (c) 2023 Chiho Sumitomo; Yohei Iwata; Yasuhiro Sakai, Tetsuya Tsukamoto, Kazumitsu Sugiura
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
